SPRINGFIELD – The rising price of insulin has forced more and more Illinoisans to make a choice between putting food on their family’s table and purchasing medication they need to survive.

State Senator Don Harmon (D-Oak Park) praised his colleague State Senator Andy Manar (D-Bunker Hill) for working tirelessly to cap patients’ out-of-pocket costs for prescription insulin at $100 for a 30-day supply.

Harmon co-sponsored Senate Bill 667, which passed the Senate and is headed to the full House for consideration.

“If you have diabetes, insulin is not optional, and no one should have to worry about how they will afford their next prescription,” Harmon said. “I am proud to have sponsored this bill, which will put fewer people’s lives at risk through rationing their supply or seeking a lower quality option.”

About 1.3 million adults in Illinois have diabetes – 12.5% of the state’s population – according to the Illinois Department of Public Health. Those people are forced to pay approximately $475 monthly on insulin, the Health Care Cost Institute reports.

“As lawmakers, we are responsible for prioritizing the health and well-being of all residents of Illinois,” Harmon said. “The passage of this measure is a step in the right direction to help thousands of people in need. I urge the members of the House to support SB 667.”

If passed by the House and signed by the governor, who previously pledged his support of the measure, Illinois will be the second state in the country to cap out-of-pocket prices.